Non-typeable <i>Haemophilus influenzae</i> airways infection: the next treatable trait in asthma?

"Conflict of interest: M.A. Brown, M. Jabeen and G. Bharj declare they have no conflicts of interest. T.S.C. Hinks has received grant support from the Wellcome Trust (211050/Z/18/z, 211050/Z/18/A) to investigate NTHi and mechanisms of macrolide efficacy in asthma, and from Pfizer to conduct a clinical trial into the role of azithromycin in SARS-CoV-2 infection."

"Conflict of interest: M.A. Brown, M. Jabeen and G. Bharj declare they have no conflicts of interest. T.S.C. Hinks has received grant support from the Wellcome Trust (211050/Z/18/z, 211050/Z/18/A) to investigate NTHi and mechanisms of macrolide efficacy in asthma, and from Pfizer to conduct a clinical trial into the role of azithromycin in SARS-CoV-2 infection. Support statement: This work was supported by a Clarendon Scholarship (to M.A. Brown) and grants from the Wellcome Trust (211050/Z/18/z, 211050/Z/18/A) and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) (to T.S.C. Hinks and M. Jabeen). The views expressed are those of the authors and not those of the NHS or NIHR."